Society for research on nicotine and tobacco

Addiction

Volumn 93, Issue 6, 1998, Pages 907-923

  Heishman, Stephen J ^a,h   Henningfield, Jack E ^b   Kendler, Kenneth S ^c   Le Houezec, Jacques ^d   Malin, David H ^e   Pomerleau, Ovide F ^f   Schneider, Nina G ^g  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b PINNEY ASSOCIATES   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h NIDA Addiction Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; TOBACCO SMOKE;

AGING; CONFERENCE PAPER; DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; GENETIC EPIDEMIOLOGY; HUMAN; MENTAL DISEASE; MORBIDITY; MORTALITY; PUBLIC HEALTH; SMOKING CESSATION; TOBACCO;

EID: 0031805781     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.1998.93690712.x     Document Type: Conference Paper

References (10)

1. BALFOUR, D. J. & FAGERSTRÖM, K. O. (1996) Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders, Pharmacology and Therapeutics, 72, 51-81.
2. COLLINS, A. C. (1990) Genetic influences on tobacco use: a review of human and animal studies, International Journal of the Addictions, 25, 35-55.
3. COVEY, L., GLASSMAN, S. & STETNER, F. (1998) Cigarette smoking and major depression, Journal of Addictive Disease, 17, 35-46.
4. LEVIN E. D., WILSON, W., ROSE, J. E. & MCEVOY, J. (1996) Nicotine-haloperidol interactions and cognitive performance in schizophrenics, Neuropsychopharmacology, 15, 429-436.
5. MALIN, D. H., LAKE J. R., PAYNE, M. C. et al. (1996) Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible, Pharmacology, Biochemistry and Behavior, 53, 81-85.
6. NATIONAL CANCER INSTITUTE (1997) Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control (Bethesda, National Institutes of Health).
7. POMERLEAU, O. F. (1995) Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence, Behavior Genetics, 25, 161-77.
8. SCHMITZ, J. M., SCHNEIDER, N. G. & JARVIK, M. E. (1997) Nicotine, in: LOWINSON, J. H., RUIZ, P., MILLMAN, R. B. & LANGROD, J. G. (Eds) Substance Abuse: a comprehensive textbook, pp. 276-294 (Baltimore, Williams & Wilkins).
9. SHARPE J. P. & GILBERT, D. G. (1998) Effects of repeated administration of the Beck Depression Inventory and other measures of negative mood states, Personality and Individual Differences, in press.
10. SLADE, J. (1993) Nicotine delivery devices, in: ORLEANS, C. T. & SLADE, J. (Eds) Nicotine Addiction: principles and management, pp. 3-23 (New York, Oxford University Press).